TWO ENZYMES TO BIODEGRADE POLYETHYLENE

CSIC has developed a method for biodegrading polyolefin-derived polymers using two enzymes Demetra and Ceres. The invention falls within the field of…

NOVEL BIOMARKERS AND RISK SCORE FOR THE PROGNOSIS OF EARLY STAGE COLORECTAL CANCER PATIENTS AND FOR PROVIDING PERSONALIZED MEDICINE

CSIC has developed a risk score method based on six novel biomarkers for determining the prognosis of patients at early stage of colorectal cancer (…

NEW DNA SARS-COV-2 VACCINE

CSIC has developed an efficient DNA SARS-CoV-2 vaccine prototype based on the combined administration of the spike (S) glycoprotein as well as the…

PEPTIDES FOR THE TREATMENT OF RETINITIS PIGMENTOSA

CSIC discloses peptides for use in the treatment of retinitis pigmentosa. This invention belongs to the field of vision health. Industrial partners…

NEW MOLECULES THAT PROMOTE IN VITRO PLANT REGENERATION THROUGH CELL REPROGRAMMING TOWARDS PLANT EMBRYOGENESIS OR MICROCALLUS FORMATION

CSIC, the Albert-Ludwigs University of Freiburg and the ScreenSYS company have found several molecules and their protocols to promote in vitro plant…

DOUBLE AND INDUCIBLE SUICIDE GENE CONSTRUCT FOR GENE THERAPY

CSIC has developed a double and inducible suicide gene construct that combines the cell death-inducing capacity of two suicide genes: HSV-TK/GCV and…

A BIOCATALYST HAS BEEN DESIGNED TO WORK AT ALKALINE PH AND HIGH TEMPERATURE TO DEGRADE LIGNIN IN THE WOOD CONVERSION SECTOR

CSIC has developed a set of tailor-made alkaliphilic and thermotolerant enzymes (laccases) for use in wood conversion industrial processes, such as…

NEW ANTIVIRAL AGENTS FOR THE TREATMENT AND / OR PREVENTION OF DISEASES CAUSED BY VIRUSES, SUCH AS EBOLA (EBOV) AND AFRICAN SWINE FEVER (ASF)

The CSIC and FIB Hospital 12 de Octubre have identified the use of a family of chemical compounds as antiviral agents, being useful for the treatment…

DRUG REPURPOSING AGAINST PNEUMOCOCCUS AND OTHER STREPTOCOCCUS GENUS SPECIES

CSIC has developed a patent for the use of 7 drugs as novel antimicrobials that display bactericidal activity against Streptococcus pneumoniae (…

PURINE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

CSIC has synthesized several substituted purine derivatives that are capable of inhibiting the activity of the CDC7 kinase. This inhibitory activity…